RxDoctor Payments Data

Garrett Gilmore, DO

Family Medicine · Columbus, OHNPI 1093291148

Payments from drug & device makers

$2,003in general payments, 2019–2025

Across 41 payments — averaging $48.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$886
  • AbbVie$245
  • Lilly USA, LLC$220
  • Stryker$175
  • Exact Sciences$143
  • Viiv Healthcare Company$122
  • plus $212 from 6 others

What the payments were for

  • Food & beverage$2,003100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,003 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$96,100
Medicare patients
574
Services billed
1,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide17$17,214
EliquisApixaban15$16,408
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$15,100
FarxigaDapagliflozin Propanediol11$6,416
Rosuvastatin Calcium59$1,124
Albuterol Sulfate HfaAlbuterol Sulfate38$1,016
Celecoxib16$690
Gabapentin45$542
Metformin Hcl ErMetformin Hcl31$535
Atorvastatin Calcium59$520
Metoprolol Succinate37$463
Chlorthalidone14$364
Lisinopril62$345
Omeprazole28$333
Pantoprazole Sodium26$323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$220$17,21417 claims
GSKTrelegy Ellipta$33$15,10019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →